FLASH irradiation reduces astrocyte injury but intensifies glioma metabolic stress in vitro
At 8 Gy, astrocyte injury was approximately 35% with FLASH versus 65% with conventional irradiation, alongside persistent glioma-cell metabolic stress.
At 8 Gy, astrocyte injury was approximately 35% with FLASH versus 65% with conventional irradiation, alongside persistent glioma-cell metabolic stress.
Two weeks after proton FLASH, normal tongue tissue retained more triglycerides and showed distinct lipid-remodeling responses compared with conventional irradiation.
FLASH RT preserved tumor-draining lymphocyte populations and increased intratumoral CD8+ infiltration compared with conventional dose-rate irradiation in HPV-positive mouse models.
A nonclinical time-driven PBS configuration delivered 25 Gy in approximately 0.6 seconds at 42 Gy/s while preserving proton range and scanning accuracy.
Five proton centres outline why conventional radiation protection workflows cannot simply be assumed adequate for ultra-high dose-rate FLASH research.
Bragg peak FLASH achieved high ultra-high-dose-rate coverage with similar target coverage to conventional IMPT, but produced higher target and CNS hotspots.
FLASH protons largely preserved ocular structure and retinal function after 24 Gy while maintaining short-term tumor control in mice.
Hybrid ultra-high and conventional dose-rate irradiation retained FLASH sparing in mice, but protection diminished as the ultra-high-rate dose contribution decreased.
Hollow 3D-printed proton collimators and compensators were produced within 45 minutes and accurately shaped small experimental proton fields.
Both dose rates increased mitochondrial respiration after irradiation, with no clear FLASH-specific mitochondrial phenotype under normoxic conditions.
Ultra-high dose-rate protons produced fewer DNA breaks at low scavenger concentration, but the effect diminished or reversed under other experimental conditions.
TLD-100 over-responded below 7 Gy/s and under-responded above 300 Gy/s, despite remaining dose-independent from 3 to 18 Gy.
Electron FLASH changed DNA-damage, transcriptomic, cytokine, and microtubule responses but did not alter clonogenic survival under normoxic conditions.
Preclinical lung studies support normal-tissue sparing, but uncertain biological thresholds, dose conformity, and respiratory motion still prevent clinical implementation.
In 10 recurrent glioblastoma replans, Bragg peak proton FLASH improved conformity and reduced estimated beam delivery from approximately 17 minutes to under two seconds.